Main Article Content

Dr. Biswaranjan Prusty
Dr.Ansuman Pradhan
Dr. Nilamadhaba Prusty
Dr. Dillip Kumar Pradhan


male breast cancer, breast‑conserving operation, modified radical mastectomy


Background: Current treatment guidelines for male breast cancer (MBC) are largely based on clinical trials limited to female participants. With limited MBC research, it remains unclear if breast conservative therapy (BCT) is equivalent to mastectomy in MBC. 

Aim and objective: To evaluate the clinical efficacy and prognosis of breast‑conserving surgery versus modified radical mastectomy in the treatment of early-stage breast cancer. 

Methods: 60 cases of early-stage breast cancer were reviewed and retrospectively included in  Department of General Surgery, Different private Hospitals, Puri, Bhubaneswar, Odisha. The characteristics of the operation procedure, such as operation time, intraoperative blood loss, and length of hospital stay, were compared between the two groups. And the prognosis was that the that the recurrence rate was also compared to the two groups.

Results: Of the 60 early breast cancer cases included, 30 subjects received the breast-conserving operation, and the other 30 cases received the modified radical mastectomy. The operation time, intraoperative blood loss, and length of hospital stay were (58.6 ± 5.02) min, (40.73 ± 4.61) ml, (11.73 ± 2.06) day in the breast‑conserving group, and (98.73 ± 5.57) min, (80.65 ± 4.99) ml, (13.53 ± 1.85) day in the modified radical mastectomy group,, respectively. The operation time, intraoperative blood loss, and length of hospital stay were smaller in the breast-conserving group compared with the modified radical mastectomy group, with a statistical difference of P < 0.05. Conclusions: The breast-conserving operation was superior to a modified radical mastectomy in terms of operation time, intraoperative blood loss, and length of hospital stay.


Abstract 30 | PDF Downloads 16


1. Siegel RL, Miller KD, Jemal A. Cancer Statistics, 2017. CA Cancer J Clin. 2017;67(1):7–30.
2. Gradishar WJ, Anderson BO, Balassanian R, Blair SL, Burstein HJ, Cyr A, et al. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Breast Cancer, Version 2.2017.
3. Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347(16):1233–41.
4. Korde LA, Zujewski JA, Kamin L, et al. Multidisciplinary meeting on male breast cancer: summary and research recommendations. J Clin Oncol 4 20 2010;28(12):2114–2122.
5. Fentiman IS, Fourquet A, Hortobagyi GN. Male breast cancer. Lancet 2 18 2006;367(9510):595–604.
6. Greif JM, Pezzi CM, Klimberg VS, Bailey L, Zuraek M. Gender differences in breast cancer: analysis of 13,000 breast cancers in men from the National Cancer Data Base. Ann Surg Oncol 10
7. 2012;19(10):3199–3204
8. Massarweh SA, Sledge GW, Miller DP, McCullough D, Petkov VI, and Shak S. Molecular Characterization and Mortality from Breast Cancer in Men. J Clin Oncol 5 10 2018;36(14):1396–1404.
9. Halverson KJ, Taylor ME, Perez CA, Myerson R, Philpott G, Simpson JR, et al. Survival following breast-conserving surgery and irradiation or modified radical mastectomy in patients with invasive breast cancers with a maximum diameter of 1 cm. Mo Med 1993;90:759-63.
10. Halsted CP, Benson JR, and Jatoi I. A historical account of breast cancer surgery: Beware of local recurrence but be not radical. Future Oncol 2014;10:1649–57.
11. Delpech Y, Barranger E. Breast cancer surgery. Rev Prat 2013;63:1395–9.
12. van de Water W, Bastiaannet E, Scholten AN, Kiderlen M, de Craen AJ, Westendorp RG, et al. Breast-conserving surgery with or without radiotherapy in older breast patients with early-stage breast cancer: A systematic review and meta-analysis. Ann Surg Oncol 2014;21:786–94.
13. Boxer MM, Delaney GP, Chua BH. A review of the management of ductal carcinoma in situ following breast conserving surgery. Breast 2013;22:1019 25
14. Borgen PI, Heerdt AS, Moore MP, and Petrek JA. Breast conservation therapy for invasive carcinoma of the breast. Curr Probl Surg 1995;32:191–248.
15. Cloyd JM, Hernandez-Boussard T, and Wapnir IL. Poor compliance with breast cancer treatment guidelines in men undergoing breast-conserving surgery. Breast Cancer Res Treat. 2013;139(1):177–82.
16. Zaenger D, Rabatic BM, Dasher B, and Mourad WF. Is breast conserving therapy a safe modality for early-stage male breast cancer? Clin Breast Cancer. 2016;16(2):101–4.
17. Golshan M, Rusby J, Dominguez F, Smith BL. Breast conservation for male breast carcinoma. 2007;16(6):653-6.
18. Madden NA, Macdonald OK, Call JA, Schomas DA, Lee CM, Patel S. Radiotherapy and Male Breast Cancer: A Population-Based Registry Analysis. Am J Clin Oncol. 2016;39(5):458–62.
19. O’Malley CD, Prehn AW, Shema SJ, Glaser SL. Racial and ethnic differences in survival rates in a population-based series of men with breast carcinoma. Cancer. 2002;94(11):2836–43.

Most read articles by the same author(s)